The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.
Eliseeva A.R.
Penza State University
Onchina V.S.
Penza State University
Modern principles of therapy for patients with spinal muscular atrophy
Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2023;123(3): 34‑40
Views: 2182
Downloaded: 50
To cite this article:
Bofanova NS, Eliseeva AR, Onchina VS. Modern principles of therapy for patients with spinal muscular atrophy. S.S. Korsakov Journal of Neurology and Psychiatry.
2023;123(3):34‑40. (In Russ.)
https://doi.org/10.17116/jnevro202312303134
Spinal muscular atrophy (SMA) is a common cause of childhood mortality among hereditary diseases of the central nervous system, which are caused by the processes of degeneration and death of motor neurons of the anterior horns of the spinal cord. An urgent issue of modern neurology is pathogenetic therapy for this group of patients, the purpose of which is to increase the level of motoneuron survival protein. We performed a search on current methods of treating SMA in Web of Science, Scopus, PubMed, Embase by the keywords: spinal muscular atrophy, neuromuscular diseases, pathogenetic therapy. Significant progress has been made in the treatment of SMA over the past 7 years. A major advance is the introduction of disease-modifying therapies using SMN2 splicing modulation or gene replacement therapy. At the moment, there are 3 FDA-approved drugs for pathogenetic therapy: Nusinersen, Risdiplam, Zolgensma. The article compares the drugs, evaluates their safety and effectiveness according to the available literature. Modern drugs for the pathogenetic therapy of SMA are highly effective and reduce the mortality rate. The results of clinical trials predict the emergence of new modern drugs. This suggests a favorable prognosis for the treatment of patients with SMA.
Authors:
Eliseeva A.R.
Penza State University
Onchina V.S.
Penza State University
Received:
29.09.2022
Accepted:
12.10.2022
List of references:
Close metadata
Email Confirmation
An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.
Email Confirmation
Log in to the site using your account in one of the services
We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.